Drug Profile
Research programme: antibody directed enzyme prodrug therapy - Genencor
Alternative Names: GCR-8886/2141Latest Information Update: 18 Dec 2023
Price :
$50
*
At a glance
- Originator Genencor International
- Class Amidohydrolases; Antibodies; Recombinant fusion proteins
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer